Literature DB >> 10544441

The increase in the steady-state level of major histocompatibility complex mRNA in the host peripheral T lymphocytes due to ischaemia-reperfusion injury.

M Nikbakht-Sangari1, A K Qayumi, V Duronio.   

Abstract

In our previous study, using a swine model of single lung transplantation, a relationship between the level of major histocompatibility complex (MHC II) expression on host T lymphocytes and the extent of the ex vivo preservation time was observed. Furthermore, a model of ischaemia by simple cross-clamping proved MHC II up-regulation to be independent of tissue incompatibility. The mechanism through which ischaemia-reperfusion injury (IRI) induces MHC up-regulation in host peripheral T cells has not been reported. The objective of this study was to determine whether IRI induces MHC II up-regulation in T cells by altering the intracellular steady-state level of MHC II mRNA. Group A (seven donors, seven recipients) was an allotransplantation model of 15 h of cold storage (4 degrees C) while in group B (n = 6) animals underwent 2 h of warm ischaemia. Group C (n = 6) underwent sham operation. For quantification of mRNA extracted from peripheral T lymphocytes isolated before and after surgery, semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to determine the time at which mRNA levels reached its peak. The mRNA at pre-reperfusion and the time, at which mRNA peaked, was used for competitive RT-PCR. The results of RT-PCR analyses demonstrated that IRI induced an increase in the steady-state level of MHC II mRNA (p < 0.02) within 2 h post-reperfusion, irrespective of type of ischaemia and tissue incompatibility. In conclusion, this study suggested that IRI up-regulates the MHC II expression in peripheral T cells by altering the intracellular steady-state level of MHC II-DR-beta.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544441     DOI: 10.1016/s0966-3274(99)80027-6

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  1 in total

1.  Alveolar macrophage secretory products effect type 2 pneumocytes undergoing hypoxia-reoxygenation.

Authors:  Anton S McCourtie; Alexander S Farivar; Steven M Woolley; Heather E Merry; Patrick S Wolf; Brendan Mackinnon-Patterson; John C Keech; Elizabeth Fitzsullivan; Michael S Mulligan
Journal:  Ann Thorac Surg       Date:  2008-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.